RxDoctor Payments Data

Michael Matthay, MD

Internal Medicine · San Francisco, CANPI 1891734497

Payments from drug & device makers

$60,258in general payments, 2019–2025

Across 29 payments — averaging $2077.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • CSL Behring$34K
  • Merck$8K
  • Shionogi Inc$7K
  • Gilead$6K
  • Terumo BCT, Inc.$3K
  • Global Blood Therapeutics, Inc.$2K
  • plus $1K from 2 others

What the payments were for

  • Consulting fees$39,91766%
  • Speaking & faculty fees$2,6644%
  • Travel & lodging$16,90728%
  • Food & beverage$7711%

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
CSL Behring11$33,547
Merck9$7,741
Shionogi Inc1$7,000
Gilead4$5,950
Terumo BCT, Inc.1$2,664
Global Blood Therapeutics, Inc.1$2,282
Jazz Pharmaceuticals Inc.1$1,050
Abbott1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$60,258 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California

Medicare billing

Part B allowed, 2024
$8,909
Medicare patients
16
Services billed
51

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →